Applications of Artificial Intelligence in Acute Promyelocytic Leukemia: An Avenue of Opportunities? A Systematic Review
Anwendungen künstlicher Intelligenz bei akuter Promyelozytenleukämie: Eine systematische Übersichtsarbeit
Journal of Clinical Medicine · 01.03.2025 · 14 (5) · 1670
DOI: 10.3390/jcm14051670 ↗Auf einen Blick
Die Übersichtsarbeit beschreibt potenzielle Anwendungen von ML, DL und anderer KI bei APL. Die eingeschlossenen Arbeiten berichten gute Leistungsmaße für Diagnose, Bewertung und Management.
Fragestellung
Welche potenziellen Anwendungen haben KI, Machine Learning und Deep Learning bei der akuten Promyelozytenleukämie (APL)?
Methode
Systematische Literaturrecherche in PubMed/MEDLINE, SCOPUS und Web of Science; 20 Manuskripte für die qualitative Analyse.
Ergebnisse
20 Manuskripte. Die Modelle basierten auf Routineparametern, Zytomorphologie, Durchflusszytometrie und/oder OMICS und zeigten gute Sensitivität, Spezifität, Accuracy und AUROC.
Schlussfolgerung der Autor:innen
KI kann ein relevantes Werkzeug zur Beurteilung von APL-Fällen sein und möglicherweise zu schnellerem Screening und schnellerer Identifikation beitragen.
Kernaussagen
- 20 Manuskripte in der qualitativen Analyse
- Anwendungen in Diagnose, Bewertung und Management von APL
- Berichtete Modelle mit guter Sensitivität, Spezifität, Accuracy und AUROC
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 01.03.2025. Verfasst von Mihnea-Alexandru Găman und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Competitiveness Operational Programme A1.1.4..
Abstract (Originalsprache)
Background
Acute promyelocytic leukemia (APL) is a subtype of acute myeloid leukemia defined by the presence of a genetic abnormality, namely the PML::RARA gene fusion, as the result of a reciprocal balanced translocation between chromosome 17 and chromosome 15. APL is a veritable emergency in hematology due to the risk of early death and coagulopathy if left untreated; thus, a rapid diagnosis is needed in this hematological malignancy. Needless to say, cytogenetic and molecular biology techniques, i.e., fluorescent in situ hybridization (FISH) and polymerase chain reaction (PCR), are essential in the diagnosis and management of patients diagnosed with APL. In recent years, the use of artificial intelligence (AI) and its brances, machine learning (ML), and deep learning (DL) in the field of medicine, including hematology, has brought to light new avenues for research in the fields of blood cancers. However, to our knowledge, there is no comprehensive evaluation of the potential applications of AI, ML, and DL in APL. Thus, the aim of the current publication was to evaluate the prospective uses of these novel technologies in APL.
Methods
We conducted a comprehensive literature search in PubMed/MEDLINE, SCOPUS, and Web of Science and identified 20 manuscripts eligible for the qualitative analysis.
Results
The included publications highlight the potential applications of ML, DL, and other AI branches in the diagnosis, evaluation, and management of APL. The examined AI models were based on the use of routine biological parameters, cytomorphology, flow-cytometry and/or OMICS, and demonstrated excellent performance metrics: sensitivity, specificity, accuracy, AUROC, and others.
Conclusions
AI can emerge as a relevant tool in the evaluation of APL cases and potentially contribute to more rapid screening and identification of this hematological emergency.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
- Department of Hematology, Centre of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, 022328 Bucharest, Romania.
- Department of Cellular and Molecular Pathology, Stefan S. Nicolau Institute of Virology, Romanian Academy, 030304 Bucharest, Romania.
- Clinical Laboratory Department, Fundeni Clinical Institute, 022328 Bucharest, Romania.
- Department of Hematology, Emergency University Hospital of Bucharest, 050098 Bucharest, Romania.
ORCID-Profile: Mihnea-Alexandru Găman, Monica Dugăeşescu, Dragoş Claudiu Popescu
Förderung
- Competitiveness Operational Programme A1.1.4.
Zitieren
APA
Găman, M. A., Dugăeşescu, M., & Popescu, D. C. (2025). Applications of Artificial Intelligence in Acute Promyelocytic Leukemia: An Avenue of Opportunities? A Systematic Review. Journal of Clinical Medicine, 14(5), 1670. https://doi.org/10.3390/jcm14051670
Vancouver
Găman MA, Dugăeşescu M, Popescu DC. Applications of Artificial Intelligence in Acute Promyelocytic Leukemia: An Avenue of Opportunities? A Systematic Review. Journal of Clinical Medicine. 2025;14(5):1670. doi:10.3390/jcm14051670
BibTeX
@article{Gman2025,
author = {Găman, Mihnea-Alexandru and Dugăeşescu, Monica and Popescu, Dragoş Claudiu},
title = {Applications of Artificial Intelligence in Acute Promyelocytic Leukemia: An Avenue of Opportunities? A Systematic Review},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {5},
pages = {1670},
doi = {10.3390/jcm14051670}
}
EUVIMED